Immunoreceptor transmembrane peptides and their effect on natural killer (NK) cell cytotoxicity.
Short peptides derived from the transmembrane sequence of NK activating receptors and associated molecules were tested in vitro for inhibition of NK cell cytotoxicity using a standard (51)Cr release assay in the absence or presence of peptides. NKL23 cell line was used as the NK effector and the target was the NKL23 sensitive 721.221 cell line. NKp46, NKp30, NKG2D and CD3-zeta peptides inhibited NK activity at higher concentration (100 microM) compared to controls by 6-13% (p<0.05). Modification of one non-effective peptide (NKP44) significantly enhanced inhibition by 30%, 17% and 11% at 100 microM, 50 microM and 10 microM respectively compared to controls. A T-cell antigen receptor-alpha chain transmembrane sequence derived peptide (CP) significantly inhibited NKL cell activation by 20-30% (p<0.05) at 50 microM and 100 microM concentrations compared to the control. The structural similarities between these immuno-receptors, and in particular the need for transmembrane electrostatic interactions for receptor function, provides the basis for current and future targeted therapeutic strategies.
Vandebona
Himesha
H
Rheumatology Department, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia.
Ali
Marina
M
Amon
Michael
M
Bender
Veronika
V
Manolios
Nicholas
N
D000595:Amino Acid Sequence; D002460:Cell Line; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry*; D007694:Killer Cells, Natural / Q000276:immunology*; D008565:Membrane Proteins / Q000737:chemistry / Q000502:physiology*; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000502:physiology*; D011971:Receptors, Immunologic / Q000737:chemistry / Q000502:physiology*
D007166:Immunosuppressive Agents; D008565:Membrane Proteins; D010446:Peptide Fragments; D011971:Receptors, Immunologic